Document:

Warrant
Certificate No. PAW- __

 

NEITHER
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES
NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT
THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS
AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO
THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS.

 

	Effective
    Date: [      ], 2016	Void
    After: [       ], 2021

 

MOTUS
GI HOLDINGS, INC.

 

WARRANT
TO PURCHASE COMMON STOCK

 

Motus
GI Holdings, Inc., a Delaware corporation (the “Company”), for value received on [ ], 2016 (the
“Effective Date”), hereby issues to [ ] (the “Holder” or “Warrant Holder”)
this Warrant (the “Warrant”) to purchase, [ ] shares (each such share as from time to time adjusted
as hereinafter provided being a “Warrant Share” and all such shares being the “Warrant Shares”)
of the Company’s Common Stock (as defined below), at the Exercise Price (as defined below), as adjusted from time to time
as provided herein, on or before [ ], 2021 (the “Expiration Date”), all subject to the following terms
and conditions. This Warrant is one of a series of placement agent warrants of like tenor that have been issued in connection
with the Company’s private offering of securities pursuant to the terms of that certain Confidential Private Placement Memorandum
of the Company dated December 1, 2016, as the same may have been amended and supplemented from time to time and the Placement
Agency Agreement dated December 1, 2016, as the same may have been amended from time to time.

 

As
used in this Warrant, (i) “Business Day” means any day other than Saturday, Sunday or any other day on which
commercial banks in the City of New York, New York, are authorized or required by law or executive order to close; (ii) “Common
Stock” means the common stock of the Company, par value $0.0001 per share, including any securities issued or issuable
with respect thereto or into which or for which such shares may be exchanged for, or converted into, pursuant to any stock dividend,
stock split, stock combination, recapitalization, reclassification, reorganization or other similar event; (iii) “Exercise
Price” means $5.00 per share of Common Stock, subject to adjustment as provided herein; (iv) “Trading Day”
means any day on which the Common Stock is traded (or available for trading) on its principal trading market; and (v) “Affiliate”
means any person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common
control with, a person, as such terms are used and construed in Rule 144 promulgated under the Securities Act of 1933, as amended
(the “Securities Act”).

 

    	 

    	 

    

 

1.
DURATION AND EXERCISE OF WARRANTS

 

(a)
Exercise Period. The Holder may exercise this Warrant in whole or in part on any Business Day on or before 5:00 P.M., Eastern
Time, on the Expiration Date, at which time this Warrant shall become void and of no value.

 

(b)
Exercise Procedures.

 

(i)
While this Warrant remains outstanding and exercisable in accordance with Section 1(a), in addition to the manner set forth in
Section 1(b)(ii) below, the Holder may exercise this Warrant in whole or in part at any time and from time to time by:

 

(A)
delivery to the Company of a duly executed copy of the Notice of Exercise attached as Exhibit A;

 

(B)
surrender of this Warrant to the Secretary of the Company at its principal offices or at such other office or agency as the Company
may specify in writing to the Holder; and

 

(C)
payment of the then-applicable Exercise Price per share multiplied by the number of Warrant Shares being purchased upon exercise
of the Warrant (such amount, the “Aggregate Exercise Price”) made in the form of cash, or by certified check,
bank draft or money order payable in lawful money of the United States of America or in the form of a Cashless Exercise to the
extent permitted in Section 1(b)(ii) below.

 

(ii)
At any time, the Holder may, in its sole discretion, exercise all or any part of the Warrant in a “cashless” or “net-issue”
exercise (a “Cashless Exercise”) by delivering to the Company (1) the Notice of Exercise and (2) the original
Warrant, pursuant to which the Holder shall surrender the right to receive upon exercise of this Warrant, a number of Warrant
Shares having a value (as determined below) equal to the Aggregate Exercise Price, in which case, the number of Warrant Shares
to be issued to the Holder upon such exercise shall be calculated using the following formula:

 

	 	X
    	=	Y
    * (A - B)	 
	 	 	 	A	 

 

	 	with:	X
    = 	the
    number of Warrant Shares to be issued to the Holder
	 	 	 	 
	 	 	Y
    =	the
    number of Warrant Shares with respect to which the Warrant is being exercised
	 	 	 	 
	 	 	A
    =	the
    fair value per share of Common Stock on the date of exercise of this Warrant
	 	 	 	 
	 	 	B
    =	the
    then-current Exercise Price of the Warrant

 

    	 	 -2-	 

     

    

 

Solely
for the purposes of this paragraph, “fair value” per share of Common Stock shall mean the average Closing Price
(as defined below) per share of Common Stock for the twenty (20) trading days immediately preceding the date on which the Notice
of Exercise is deemed to have been sent to the Company. “Closing Price” means, for any date, the price determined
by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on the New York Stock Exchange,
the NYSE MKT, the NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market or any other national securities
exchange, the closing price per share of the Common Stock for such date (or the nearest preceding date) on the primary eligible
market or exchange on which the Common Stock is then listed or quoted; (b) if prices for the Common Stock are then quoted on the
OTC Bulletin Board or any tier of the OTC Markets, the closing bid price per share of the Common Stock for such date (or the nearest
preceding date) so quoted; or (c) if prices for the Common Stock are then reported in the “Pink Sheets” published
by the National Quotation Bureau Incorporated (or a similar organization or agency succeeding to its functions of reporting prices),
the most recent closing bid price per share of the Common Stock so reported. If the Common Stock is not publicly traded as set
forth above, the “fair value” per share of Common Stock shall be reasonably and in good faith determined by the Board
of Directors of the Company as of the date which the Notice of Exercise is deemed to have been sent to the Company.

 

For
purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares
issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for such
shares shall be deemed to have commenced, on the Effective Date of this Warrant.

 

(iii)
Upon the exercise of this Warrant in compliance with the provisions of this Section 1(b), and except as limited pursuant to the
last paragraph of Section 1(b)(ii), the Company shall promptly issue and cause to be delivered to the Holder a certificate for
the Warrant Shares purchased by the Holder. Each exercise of this Warrant shall be effective immediately prior to the close of
business on the date (the “Date of Exercise”) that the conditions set forth in Section 1(b) have been satisfied,
as the case may be. On the first Business Day following the date on which the Company has received each of the Notice of Exercise
and the Aggregate Exercise Price (or notice of a Cashless Exercise in accordance with Section 1(b)(ii)) (the “Exercise
Delivery Documents”), the Company shall transmit an acknowledgment of receipt of the Exercise Delivery Documents to
the Company’s transfer agent (the “Transfer Agent”). On or before the third Business Day following the
date on which the Company has received all of the Exercise Delivery Documents (the “Share Delivery Date”),
the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (“DTC”)
Fast Automated Securities Transfer Program, upon the request of the Holder, credit such aggregate number of shares of Common Stock
to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC
through its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program, issue and dispatch by overnight courier to the address as specified in the Notice of Exercise, a
certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of shares
of Common Stock to which the Holder is entitled pursuant to such exercise. Upon delivery of the Exercise Delivery Documents, the
Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing such Warrant Shares.

 

    	 	 -3-	 

     

    

 

(iv)
If the Company shall fail for any reason or for no reason to issue to the Holder, within three (3) Business Days of receipt of
the Exercise Delivery Documents, a certificate for the number of shares of Common Stock to which the Holder is entitled and register
such shares of Common Stock on the Company’s share register or to credit the Holder’s balance account with DTC for
such number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise of this Warrant, and if
on or after such Business Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such exercise that the Holder anticipated receiving
from the Company (a “Buy-In”), then the Company shall, (A) pay in cash to the Holder the amount, if any, by
which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so
purchased (the “Buy-In Amount”) plus the amount paid by the Holder to the Company as the exercise price for
the Warrant Shares exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required
to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such
purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
number of Warrant Shares for which such exercise was not honored or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example,
if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of shares of Common Stock, and paid the Company $5,000 as the exercise price, the Holder’s cash outlay would be a total
of $16,000; and if the aggregate sales price of the shares giving rise to such Buy-In obligation was $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $6,000. The Holder shall provide the Company
written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder,
at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the
Company’s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required
pursuant to the terms hereof.

 

(c)
Partial Exercise. This Warrant shall be exercisable, either in its entirety or, from time to time, for part only of the
number of Warrant Shares referenced by this Warrant. If this Warrant is submitted in connection with any exercise pursuant to
Section 1 and the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the actual number
of Warrant Shares being acquired upon such an exercise, then the Company shall as soon as practicable and in no event later than
five (5) Business Days after any exercise and at its own expense, issue a new Warrant of like tenor representing the right to
purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant
Shares with respect to which this Warrant is exercised.

 

    	 	 -4-	 

     

    

 

(d)
Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute
in accordance with Section 16.

 

2.
ISSUANCE OF WARRANT SHARES

 

(a)
The Company covenants that all Warrant Shares will, upon issuance in accordance with the terms of this Warrant, be (i) duly authorized,
fully paid and non-assessable, and (ii) free from all liens, charges and security interests, with the exception of claims arising
through the acts or omissions of any Holder and except as arising from applicable Federal and state securities laws.

 

(b)
The Company shall register this Warrant upon records to be maintained by the Company for that purpose in the name of the record
holder of such Warrant from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute
owner thereof for the purpose of any exercise thereof, any distribution to the Holder thereof and for all other purposes.

 

(c)
The Company will not, by amendment of its certificate of incorporation, by-laws or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist
in the carrying out of all the provisions of this Warrant and in the taking of all action necessary or appropriate in order to
protect the rights of the Holder to exercise this Warrant, or against impairment of such rights.

 

3.
ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND TYPE OF WARRANT SHARES

 

(a)
The Exercise Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from
time to time upon the occurrence of certain events described in this Section 3; provided, that notwithstanding the provisions
of this Section 3, the Company shall not be required to make any adjustment if and to the extent that such adjustment would require
the Company to issue a number of shares of Common Stock in excess of its authorized but unissued shares of Common Stock, less
all amounts of Common Stock that have been reserved for issue upon the conversion of all outstanding securities convertible into
shares of Common Stock and the exercise of all outstanding options, warrants and other rights exercisable for shares of Common
Stock. If the Company does not have the requisite number of authorized but unissued shares of Common Stock to make any adjustment,
the Company shall use its commercially best efforts to obtain the necessary stockholder consent to increase the authorized number
of shares of Common Stock to make such an adjustment pursuant to this Section 3.

 

    	 	 -5-	 

     

    

 

(i)
Subdivision or Combination of Stock. In case the Company shall at any time subdivide (whether by way of stock dividend,
stock split or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect
immediately prior to such subdivision shall be proportionately reduced and the number of Warrant Shares shall be proportionately
increased, and conversely, in case the outstanding shares of Common Stock of the Company shall be combined (whether by way of
stock combination, reverse stock split or otherwise) into a smaller number of shares, the Exercise Price in effect immediately
prior to such combination shall be proportionately increased and the number of Warrant Shares shall be proportionately decreased.
The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening of any successive
event or events described in this Section 3(a)(i).

 

(ii)
Dividends in Stock, Property, Reclassification. If at any time, or from time to time, all of the holders of Common Stock
(or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become
entitled to receive, without payment therefore:

 

(A)
any shares of stock or other securities that are at any time directly or indirectly convertible into or exchangeable for Common
Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other
distribution, or

 

(B)
additional stock or other securities or property (including cash) by way of spin-off, split-up, reclassification, combination
of shares or similar corporate rearrangement (other than shares of Common Stock issued as a stock split or adjustments in respect
of which shall be covered by the terms of Section 3(a)(i) above),

 

then
and in each such case, the Exercise Price and the number of Warrant Shares to be obtained upon exercise of this Warrant shall
be adjusted proportionately, and the Holder hereof shall, upon the exercise of this Warrant, be entitled to receive, in addition
to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the
amount of stock and other securities and property (including cash in the cases referred to above) that such Holder would hold
on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on which holders of
Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property.
The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening of any successive
event or events described in this Section 3(a)(ii).

 

    	 	 -6-	 

     

    

 

(iii)
Reorganization, Reclassification, Consolidation, Merger or Sale. If any recapitalization, reclassification or reorganization
of the capital stock of the Company, or any consolidation or merger of the Company with another corporation, or the sale of all
or substantially all of its assets or other transaction shall be effected in such a way that holders of Common Stock shall be
entitled to receive stock, securities, or other assets or property (an “Organic Change”), then, as a condition
of such Organic Change, lawful and adequate provisions shall be made by the Company whereby the Holder hereof shall thereafter
have the right to purchase and receive (in lieu of the shares of the Common Stock of the Company immediately theretofore purchasable
and receivable upon the exercise of the rights represented by this Warrant) such shares of stock, securities or other assets or
property as may be issued or payable with respect to or in exchange for a number of outstanding shares of such Common Stock equal
to the number of shares of such stock immediately theretofore purchasable and receivable assuming the full exercise of the rights
represented by this Warrant. In the event of any Organic Change, appropriate provision shall be made by the Company with respect
to the rights and interests of the Holder of this Warrant to the end that the provisions hereof (including, without limitation,
provisions for adjustments of the Exercise Price and of the number of shares purchasable and receivable upon the exercise of this
Warrant) shall thereafter be applicable, in relation to any shares of stock, securities or assets thereafter deliverable upon
the exercise hereof. The Company will not affect any such consolidation, merger or sale unless, prior to the consummation thereof,
the successor corporation (if other than the Company) resulting from such consolidation or merger or the corporation purchasing
such assets shall assume by written instrument reasonably satisfactory in form and substance to the Holder executed and mailed
or delivered to the registered Holder hereof at the last address of such Holder appearing on the books of the Company, the obligation
to deliver to such Holder such shares of stock, securities or assets as, in accordance with the foregoing provisions, such Holder
may be entitled to purchase. If there is an Organic Change, then the Company shall cause to
be mailed to the Holder at its last address as it shall appear on the books and records of the Company, at least 10 calendar days
before the effective date of the Organic Change, a notice stating the date on which such Organic Change is expected to become
effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange
their shares for securities, cash, or other property delivered upon such Organic Change; provided, that the failure to mail such
notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified
in such notice. The Holder is entitled to exercise this Warrant during the 10-day period commencing on the date of such notice
to the effective date of the event triggering such notice. In any event, the successor corporation (if other than the Company)
resulting from such consolidation or merger or the corporation purchasing such assets shall be deemed to assume such obligation
to deliver to such Holder such shares of stock, securities or assets even in the absence of a written instrument assuming such
obligation to the extent such assumption occurs by operation of law.

 

(b)
Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 3, the Company
at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each
Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which
such adjustment or readjustment is based. The Company shall promptly furnish or cause to be furnished to such Holder a like certificate
setting forth: (i) such adjustments and readjustments; and (ii) the number of shares and the amount, if any, of other property
which at the time would be received upon the exercise of the Warrant.

 

(c)
Certain Events. If any event occurs as to which the other provisions of this Section 3 are not strictly applicable but
the lack of any adjustment would not fairly protect the purchase rights of the Holder under this Warrant in accordance with the
basic intent and principles of such provisions, or if strictly applicable would not fairly protect the purchase rights of the
Holder under this Warrant in accordance with the basic intent and principles of such provisions, then the Company’s Board
of Directors will, in good faith, make an appropriate adjustment to protect the rights of the Holder; provided, that no
such adjustment pursuant to this Section 3(c) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise
determined pursuant to this Section 3.

 

    	 	 -7-	 

     

    

 

4.
INTENTIONALLY OMITTED.

 

5.
TRANSFERS AND EXCHANGES OF WARRANT AND WARRANT SHARES

 

(a)
Registration of Transfers and Exchanges. Subject to Section 5(c), upon the Holder’s surrender of this Warrant, with
a duly executed copy of the Form of Assignment attached as Exhibit B, to the Secretary of the Company at its principal
offices or at such other office or agency as the Company may specify in writing to the Holder, the Company shall register the
transfer of all or any portion of this Warrant. Upon such registration of transfer, the Company shall issue a new Warrant, in
substantially the form of this Warrant, evidencing the acquisition rights transferred to the transferee and a new Warrant, in
similar form, evidencing the remaining acquisition rights not transferred, to the Holder requesting the transfer.

 

(b)
Warrant Exchangeable for Different Denominations. The Holder may exchange this Warrant for a new Warrant or Warrants, in
substantially the form of this Warrant, evidencing in the aggregate the right to purchase the number of Warrant Shares which may
then be purchased hereunder, each of such new Warrants to be dated the date of such exchange and to represent the right to purchase
such number of Warrant Shares as shall be designated by the Holder. The Holder shall surrender this Warrant with duly executed
instructions regarding such re-certification of this Warrant to the Secretary of the Company at its principal offices or at such
other office or agency as the Company may specify in writing to the Holder.

 

(c)
Restrictions on Transfers. This Warrant may not be transferred at any time without (i) registration under the Securities
Act or (ii) an exemption from such registration and a written opinion of legal counsel addressed to the Company that the proposed
transfer of the Warrant may be effected without registration under the Securities Act, which opinion will be in form and from
counsel reasonably satisfactory to the Company.

 

(d)
Permitted Transfers and Assignments. Notwithstanding any provision to the contrary in this Section 5, the Holder may transfer,
with or without consideration, this Warrant or any of the Warrant Shares (or a portion thereof) to the Holder’s Affiliates
(as such term is defined under Rule 144 of the Securities Act) without obtaining the opinion from counsel that may be required
by Section 5(c)(ii), provided, that the Holder delivers to the Company and its counsel certification, documentation, and
other assurances reasonably required by the Company’s counsel to enable the Company’s counsel to render an opinion
to the Company’s Transfer Agent that such transfer does not violate applicable securities laws.

 

    	 	 -8-	 

     

    

 

6.
MUTILATED OR MISSING WARRANT CERTIFICATE

 

If
this Warrant is mutilated, lost, stolen or destroyed, upon request by the Holder, the Company will, at its expense, issue, in
exchange for and upon cancellation of the mutilated Warrant, or in substitution for the lost, stolen or destroyed Warrant, a new
Warrant, in substantially the form of this Warrant, representing the right to acquire the equivalent number of Warrant Shares;
provided, that, as a prerequisite to the issuance of a substitute Warrant, the Company may require satisfactory evidence
of loss, theft or destruction as well as an indemnity from the Holder of a lost, stolen or destroyed Warrant.

 

7.
PAYMENT OF TAXES

 

The
Company will pay all transfer and stock issuance taxes attributable to the preparation, issuance and delivery of this Warrant
and the Warrant Shares (and replacement Warrants) including, without limitation, all documentary and stamp taxes; provided,
however, that the Company shall not be required to pay any tax in respect of the transfer of this Warrant, or the issuance
or delivery of certificates for Warrant Shares or other securities in respect of the Warrant Shares to any person or entity other
than to the Holder.

 

8.
FRACTIONAL WARRANT SHARES

 

No
fractional Warrant Shares shall be issued upon exercise of this Warrant. The Company, in lieu of issuing any fractional Warrant
Share, shall round up the number of Warrant Shares issuable to nearest whole share.

 

9.
NO STOCK RIGHTS AND LEGEND

 

No
holder of this Warrant, as such, shall be entitled to vote or be deemed the holder of any other securities of the Company that
may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to confer upon the holder
of this Warrant, as such, the rights of a stockholder of the Company or the right to vote for the election of directors or upon
any matter submitted to stockholders at any meeting thereof, or give or withhold consent to any corporate action or to receive
notice of meetings or other actions affecting stockholders (except as provided herein), or to receive dividends or subscription
rights or otherwise (except as provide herein).

 

Each
certificate for Warrant Shares initially issued upon the exercise of this Warrant, and each certificate for Warrant Shares issued
to any subsequent transferee of any such certificate, shall be stamped or otherwise imprinted with a legend in substantially the
following form:

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR
OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE
SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER
OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED,
SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR
APPLICABLE STATE SECURITIES LAWS.”

 

    	 	 -9-	 

     

    

 

10.
INTENTIONALLY OMITTED.

 

11.
NOTICES

 

All
notices, consents, waivers, and other communications under this Warrant must be in writing and will be deemed given to a party
when (a) delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); (b)
sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment; (c) received or rejected by the addressee,
if sent by certified mail, return receipt requested, if to the registered Holder hereof; or (d) seven days after the placement
of the notice into the mails (first class postage prepaid), to the Holder at the address, facsimile number, or e-mail address
furnished by the registered Holder to the Company, or if to the Company, to it at 150 Union Square Drive, New Hope, PA 18938,
Attn: Mark Pomeranz, CEO (or to such other address, facsimile number, or e-mail address as the Holder or the Company as a party
may designate by notice the other party).

 

12.
SEVERABILITY

 

If
a court of competent jurisdiction holds any provision of this Warrant invalid or unenforceable, the other provisions of this Warrant
will remain in full force and effect. Any provision of this Warrant held invalid or unenforceable only in part or degree will
remain in full force and effect to the extent not held invalid or unenforceable.

 

 

13.
BINDING EFFECT

 

This
Warrant shall be binding upon and inure to the sole and exclusive benefit of the Company, its successors and assigns, the registered
Holder or Holders from time to time of this Warrant and the Warrant Shares.

 

14.
SURVIVAL OF RIGHTS AND DUTIES

 

This
Warrant shall terminate and be of no further force and effect on the earlier of 5:00 P.M., Eastern Time, on the Expiration Date
or the date on which this Warrant has been exercised in full.

 

    	 	 -10-	 

     

    

 

15.
GOVERNING LAW

 

This
Warrant will be governed by and construed under the laws of the State of New York without regard to conflicts of laws principles
that would require the application of any other law.

 

16.
DISPUTE RESOLUTION

 

In
the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company
shall submit the disputed determinations or arithmetic calculations via facsimile within two Business Days of receipt of the Notice
of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree
upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed
determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two Business Days, submit
via facsimile (a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the
Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent,
outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform
the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from
the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s determination
or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

17.
NOTICES OF RECORD DATE

 

Upon
(a) any establishment by the Company of a record date of the holders of any class of securities for the purpose of determining
the holders thereof who are entitled to receive any dividend or other distribution, or right or option to acquire securities of
the Company, or any other right, or (b) any capital reorganization, reclassification, recapitalization, merger or consolidation
of the Company with or into any other corporation, any transfer of all or substantially all the assets of the Company, or any
voluntary or involuntary dissolution, liquidation or winding up of the Company, or the sale, in a single transaction, of a majority
of the Company’s voting stock (whether newly issued, or from treasury, or previously issued and then outstanding, or any
combination thereof), the Company shall mail to the Holder at least ten (10) Business Days, or such longer period as may be required
by law, prior to the record date specified therein, a notice specifying (i) the date established as the record date for the purpose
of such dividend, distribution, option or right and a description of such dividend, option or right, (ii) the date on which any
such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or winding up, or sale is expected
to become effective and (iii) the date, if any, fixed as to when the holders of record of Common Stock shall be entitled to exchange
their shares of Common Stock for securities or other property deliverable upon such reorganization, reclassification, transfer,
consolation, merger, dissolution, liquidation or winding up.

 

    	 	 -11-	 

     

    

 

18.
RESERVATION OF SHARES

 

The
Company shall reserve and keep available out of its authorized but unissued shares of Common Stock for issuance upon the exercise
of this Warrant, free from pre-emptive rights, such number of shares of Common Stock for which this Warrant shall from time to
time be exercisable. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may
be issued as provided herein without violation of any applicable law or regulation. Without limiting the generality of the foregoing,
the Company covenants that it will use commercially reasonable efforts to take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this
Warrant and use commercially reasonable efforts to obtain all such authorizations, exemptions or consents, including but not limited
to consents from the Company’s stockholders or Board of Directors or any public regulatory body, as may be necessary to
enable the Company to perform its obligations under this Warrant.

 

19.
NO THIRD PARTY RIGHTS

 

This
Warrant is not intended, and will not be construed, to create any rights in any parties other than the Company and the Holder,
and no person or entity may assert any rights as third-party beneficiary hereunder.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	 	 -12-	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the date first set forth above.

 

MOTUS
GI HOLDINGS, INC.

 

	By:	 	 
	Name:
    	Mark
    Pomeranz	 
	Title:
    	Chief
    Executive Officer	 

 

[Signature
Page to Placement Agent Warrant]

 

    	 

    	 

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

(To
be executed by the Holder of Warrant if such Holder desires to exercise Warrant)

 

To
Motus GI Holdings, Inc.:

 

The
undersigned hereby irrevocably elects to exercise this Warrant and to purchase thereunder, ___________________ full shares of
Motus GI Holdings, Inc. common stock issuable upon exercise of the Warrant and delivery of:

 

(1)
$_________ (in cash as provided for in the foregoing Warrant) and any applicable taxes payable by the undersigned pursuant to
such Warrant; and

 

(2)
__________ shares of Common Stock (pursuant to a Cashless Exercise in accordance with Section 1(b)(ii) of the Warrant) (check
here if the undersigned desires to deliver an unspecified number of shares equal the number sufficient to effect a Cashless Exercise
[___]).

 

The
undersigned requests that certificates for such shares be issued in the name of:

 

 

 

(Please
print name, address and social security or federal employer

identification number (if applicable))

 

 

 

 

 

The
undersigned hereby affirms that the undersigned is an accredited investor as defined under Rule 501 of Regulation D of the Securities
Act of 1933. If the Holder cannot make the foregoing affirmation because it is factually incorrect, it shall be a condition to
the exercise of the Warrant that the Company receive such other representations as the Company considers necessary, acting reasonably,
to assure the Company that the issuance of securities upon exercise of this Warrant shall not violate any United States or other
applicable securities laws.

 

If
the shares issuable upon this exercise of the Warrant are not all of the Warrant Shares which the Holder is entitled to acquire
upon the exercise of the Warrant, the undersigned requests that a new Warrant evidencing the rights not so exercised be issued
in the name of and delivered to:

 

 

 

(Please
print name, address and social security or federal employer

identification
number (if applicable))

 

 

 

 

 

	 	Name of
Holder (print): _____________________________
	 	(Signature):__________________________________
	 	(By:)______________________________________
	 	(Title:)_____________________________________
	 	Dated:__________________________________________

 

    	 

    	 

    

 

EXHIBIT
B

 

FORM
OF ASSIGNMENT

 

FOR
VALUE RECEIVED, ___________________________________ hereby sells, assigns and transfers to each assignee set forth below all of
the rights of the undersigned under the Warrant (as defined in and evidenced by the attached Warrant) to acquire the number of
Warrant Shares set opposite the name of such assignee below and in and to the foregoing Warrant with respect to said acquisition
rights and the shares issuable upon exercise of the Warrant:

 

	Name
of Assignee	 	Address	 	Number
    of Shares
	

         
	 	 	 	 
	

         
	 	 	 	 
	

         
	 	 	 	 
	

         
	 	 	 	 

 

If
the total of the Warrant Shares are not all of the Warrant Shares evidenced by the foregoing Warrant, the undersigned requests
that a new Warrant evidencing the right to acquire the Warrant Shares not so assigned be issued in the name of and delivered to
the undersigned.

 

	 	Name of
Holder (print): _________________________
	 	(Signature):__________________________________
	 	(By:)______________________________________
	 	(Title:)_____________________________________
	 	Dated:__________________________________________REGISTRATION
RIGHTS AGREEMENT

 

This
Registration Rights Agreement (this “Agreement”) is made and entered into effective as of December 22, 2016
(the “Effective Date”) between Motus GI Holdings, Inc., a Delaware corporation (the “Company”),
and the persons who have executed the signature page(s) hereto (each, a “Purchaser” and collectively, the “Purchasers”).

 

RECITALS:

 

WHEREAS,
the Company has entered into a Share Exchange Agreement with Motus GI Medical Technology Ltd., an Israeli company (“Motus”),
the stockholders of Motus and the other parties named therein, pursuant to which the stockholders of Motus agreed to exchange
all of the issued and outstanding shares of the capital stock of Motus for shares of common stock, par value $.0001 per share
of the Company, and Motus became a wholly-owned subsidiary of the Company (the “Share Exchange”) contemporaneously
with the PPO (as defined below);

 

WHEREAS,
simultaneously with the Share Exchange and to provide the capital required by the Company for working capital and other purposes,
the Company has offered in compliance with Rule 506(b) of Regulation D of the Securities Act (as defined herein), to accredited
investors in a private placement transaction (the “PPO”), units (each, a “Unit” and collectively,
the “Units”) of its securities, each consisting of (i) a three-quarter (3/4) share of Common Stock (the “Unit
Common Stock”), and (ii) one-quarter (1/4) share of Series A Preferred Stock;

 

WHEREAS,
the Series A Preferred Stock is convertible on a one for one basis into shares of Common Stock (the “Series A Common
Stock,” and together with the Unit Common Stock, the “Investor Shares”);

 

WHEREAS,
the initial closing of the PPO and the closing of the Share Exchange have taken place on the Effective Date;

 

WHEREAS,
simultaneously with the Share Exchange and the PPO, certain of the Company’s convertible notes held by certain investors
(the “Note Holders”) in the aggregate principal amount of $13,746,017 (the “Notes”), will
automatically convert into a quantity of Units equal to the principal amount of Notes held by such Note Holders, together with
accrued interest thereon calculated through the date of the initial closing of the PPO, divided by $4.50 (the “Conversion”);
and

 

WHEREAS,
in connection with the Share Exchange and the PPO, the Company agreed to provide certain registration rights related to the Investor
Shares, on the terms set forth herein.

 

NOW,
THEREFORE, in consideration of the mutual promises, representations, warranties, covenants, and conditions set forth herein, the
parties mutually agree as follows:

 

1.
Certain Definitions. As used in this Agreement, the following terms shall have the following respective meanings:

 

“Agreement”
has the meaning given it in the preamble to this Agreement.

 

    	 	-1-	 

     

    

 

“Allowed
Delay” has the meaning given it in Section 3(e) of this Agreement.

 

“Approved
Market” means the Over-the-Counter Bulletin Board, the OTC Markets, the Nasdaq Stock Market, the New York
Stock Exchange or the NYSE MKT.

 

“Blackout
Period” means, with respect to a registration, a period, in each case commencing on the day immediately after the Company
notifies the Purchasers that they are required, because of the occurrence of an event of the kind described in Section 4(f) hereof,
to suspend offers and sales of Registrable Securities during which the Company, in the good faith judgment of its board of directors,
determines (because of the existence of, or in anticipation of, any acquisition, financing activity, or other transaction involving
the Company, or the unavailability for reasons beyond the Company’s control of any required financial statements, disclosure
of information which is in its best interest not to publicly disclose, or any other event or condition of similar significance
to the Company) that the registration and distribution of the Registrable Securities to be covered by such Registration Statement,
if any, would be seriously detrimental to the Company and its stockholders and ending on the earlier of (1) the date upon which
the material non-public information commencing the Blackout Period is disclosed to the public or ceases to be material and (2)
such time as the Company notifies the selling Holders that the Company will no longer delay such filing of the Registration Statement,
recommence taking steps to make such Registration Statement effective, or allow sales pursuant to such Registration Statement
to resume.

 

“Business
Day” means any day of the year, other than a Saturday, Sunday, or other day on which the Commission is required or authorized
to close.

 

“Commission”
means the U. S. Securities and Exchange Commission or any other applicable federal agency at the time administering the
Securities Act.

 

“Common
Stock” means the common stock, par value $0.0001 per share, of the Company and any and all shares of capital stock
or other equity securities of: (i) the Company which are added to or exchanged or substituted for the Common Stock by reason
of the declaration of any stock dividend or stock split, the issuance of any distribution or the reclassification,
readjustment, recapitalization or other such modification of the capital structure of the Company; and (ii) any other
corporation, now or hereafter organized under the laws of any state or other governmental authority, with which the Company
is merged, which results from any consolidation or reorganization to which the Company is a party, or to which is sold all or
substantially all of the shares or assets of the Company, if immediately after such merger, consolidation, reorganization or
sale, the Company or the stockholders of the Company own equity securities having in the aggregate more than 50% of the total
voting power of such other corporation.

 

“Company”
has the meaning given it in the preamble to this Agreement. “Conversion” has the meaning given in the
recitals of this Agreement.

 

“Effective
Date” has the meaning given it in the preamble to this Agreement.

 

“Effectiveness
Period” has the meaning given it in Section 4(a) of this Agreement.

 

    	 	-2-	 

     

    

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder.

 

“Family
Member” means (a) with respect to any individual, such individual’s spouse, any descendants (whether natural or
adopted), any trust all of the beneficial interests of which are owned by any of such individuals or by any of such individuals
together with any organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, the estate of
any such individual, and any corporation, association, partnership or limited liability company all of the equity interests of
which are owned by those above described individuals, trusts or organizations and (b) with respect to any trust, the owners of
the beneficial interests of such trust.

 

“Holder”
means each Purchaser, including any Note Holder, or any of such Purchaser’s or Note Holder’s respective
successors and Permitted Assignees who acquire rights in accordance with this Agreement with respect to any Registrable
Securities directly or indirectly from a Purchaser or Note Holder or from any Permitted Assignee.

 

“Initial
Public Offering” means the initial underwritten sale of equity securities by the Company pursuant to an effective Registration
Statement under the Securities Act.

 

“IPO
Engagement” has the meaning given it in Section 3(a) of this Agreement.

 

“IPO
Process Commencement Date” has the meaning given it in Section 3(a) of this Agreement.

 

“Investor
Shares” has the meaning given it in the recitals of this Agreement.

 

“Joint
Registration Statement” has the meaning given it in Section 3(a) of this Agreement.

 

“Majority
Holders” means at any time Holders representing a majority of the Registrable Securities.

 

“Note
Holders” has the meaning given in the recitals of this Agreement.

 

“Notes”
has the meaning given in the recitals of this Agreement.

 

“Permitted
Assignee” means (a) with respect to a partnership, its partners or former partners in accordance with their partnership
interests, (b) with respect to a corporation, its stockholders in accordance with their interest in the corporation, (c) with
respect to a limited liability company, its members or former members in accordance with their interest in the limited liability
company, (d) with respect to an individual party, any Family Member of such party, (e) an entity that is controlled by, controls,
or is under common control with a transferor, or (f) a party to this Agreement.

 

“Piggyback
Registration” means, in any registration of Common Stock as set forth in Section 3(b), the ability of holders of Registrable
Securities to include Registrable Securities in such registration.

 

    	 	-3-	 

     

    

 

“PPO”
has the meaning given in the recitals of this Agreement.

 

“Purchaser”
has the meaning given it in the preamble to this Agreement.

 

“Qualified
Purchaser” has the meaning given it in Section 3(d) of this Agreement.

 

The
terms “register,” “registered,” and “registration” refer to a registration
effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering
of the effectiveness of such registration statement.

 

“Registrable
Securities” means the Investor Shares but excluding, subject to Section 3(e), (i) any Registrable Securities that have
been publicly sold or may be sold immediately without registration under the Securities Act either pursuant to Rule 144 of the
Securities Act or otherwise; (ii) any Registrable Securities sold by a person in a transaction pursuant to a registration statement
filed under the Securities Act, or (iii) any Registrable Securities that are at the time subject to an effective registration
statement under the Securities Act.

 

“Registration
Default Date” means the date that is 150 days after the date the Registration Statement is actually filed with the Commission;
provided however that the Registration Default Date is subject to adjustment as set forth under Section 3(a) of this Agreement

 

“Registration
Default Period” means the period during which any Registration Event occurs and is continuing.

 

“Registration
Event” means the occurrence of any of the following events:

 

(a)
the Company fails to file with the Commission the Registration Statement on or before the Registration Filing Date;

 

(b)
the Registration Statement is not declared effective by the Commission on or before the Registration Default Date;

 

(c)
after the SEC Effective Date, sales cannot be made pursuant to the Registration Statement for any reason (including without limitation
by reason of a stop order, or the Company’s failure to update the Registration Statement) except as excused pursuant to
Section 3(e); or

 

(d)
20 days after the SEC Effective Date, the Common Stock generally or the Registrable Securities specifically are not listed or
included for quotation on an Approved Market, or trading of the Common Stock is suspended or halted on the Approved Market, which
at the time constitutes the principal market for the Common Stock, for more than two full, consecutive Trading Days; provided,
however, that such 20 day delay in the Common Stock being listed on an Approved Market shall not be a Registration Event in the
event the delay is solely the result of issues raised by the Approved Market subsequent to the SEC Effective Date and provided
that the Company uses its commercially reasonable efforts in curing any issues resulting in such delay.

 

    	 	-4-	 

     

    

 

provided,
however, a Registration Event shall not be deemed to occur if: (1) all or substantially all trading in equity securities
(including the Common Stock) is suspended or halted on the Approved Market for any length of time; (2) the Company commences and
pursues an Initial Public Offering, as set forth in Section 3(a) of this Agreement; or (3) the Company declares a Blackout Period;
provided however that the Company shall only be permitted to declare two (2) Blackout Periods per year.

 

“Registration
Filing Date” means the date that is 60 days after date of the final closing of the PPO, or if later, the termination
of the PPO following an initial closing of the PPO; provided however, that the Registration Filing Date is subject to adjustment
as set forth under Section 3(a) of this Agreement.

 

“Registration
Statement” means the registration statement that the Company is required to file pursuant to this Agreement to register
the Registrable Securities.

 

“Rule
144” means Rule 144 promulgated by the Commission under the Securities Act.

 

“Rule
145” means Rule 145 promulgated by the Commission under the Securities Act.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such
Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such
Rule.

 

“Securities
Act” means the Securities Act of 1933, as amended, or any similar federal statute promulgated in replacement thereof,
and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

 

“SEC
Effective Date” means the date the Registration Statement is declared effective by the Commission.

 

“Series
A Preferred Stock” means the Series A Convertible Preferred stock, par value $0.0001 per share, of the
Company.

 

“Share
Exchange” has the meaning given in the recitals of this Agreement.

 

“Trading
Day” means (a) if the Common Stock is listed or quoted on an Approved Market, then any day during which securities are
generally eligible for trading on the Approved Market, or (b) if the Common Stock is not then listed or quoted and traded on an
Approved Market, then any Business Day.

 

“Units”
has the meaning given in the recitals of this Agreement.

 

2.
Term. This Agreement shall continue in full force and effect for a period of one year from the SEC Effective Date, unless
terminated sooner hereunder.

 

    	 	-5-	 

     

    

 

3. Registration.

 

(a)
Registration on Form S-1. Not later than the Registration Filing Date, the Company shall file with the Commission a Registration
Statement on Form S-1, or other applicable form, relating to the resale by the Holders of all of the Registrable Securities, and
the Company shall use its commercially reasonably efforts to cause such Registration Statement to be declared effective prior
to the Registration Default Date; provided, however, that in the event the Company signs a letter of intent or comparable
agreement with an underwriter which contemplates an Initial Public Offering or holds an organizational meeting for an Initial
Public Offering or otherwise orally engages an underwriter to begin working with the Company towards an Initial Public Offering
(an “IPO Engagement”) prior to the Registration Default Date (such applicable date, the “IPO Process
Commencement Date”), then the Company shall, in satisfaction of the foregoing obligation, file a joint registration
statement covering the primary shares to be issued in the Initial Public Offering and the resale of the Registrable Securities
(“Joint Registration Statement”), and, in such event, the Registration Filing Date shall be extended to a date
that is seventy five (75) calendar days after the IPO Process Commencement Date and the Registration Default Date shall be extended
to a date that is one hundred fifty (150) calendar days after the initial filing of the Registration Statement with the Commission.
If the Initial Public Offering is abandoned at any time, then the Registration Filing Date will be 60 calendar days from the actual
date of abandonment and the Registration Default Date will be one hundred and fifty (150) calendar days after the date of abandonment.
The registration rights under Section 3 shall not apply or be available to certain affiliate holders.

 

(b)
Piggyback Registration. In addition to the Company agreement pursuant to Section 3(a) above, if the Company shall determine
to register for sale for cash any of its Common Stock, for its own account or for the account of others (other than the Holders),
other than (i) Initial Public Offering, (ii) a registration relating solely to employee benefit plans or securities issued or
issuable to employees, consultants (to the extent the securities owned or to be owned by such consultants could be registered
on Form S-8) or any of their Family Members (including a registration on Form S-8) or (iii) a registration relating solely to
a Securities Act Rule 145 transaction or a registration on Form S-4 in connection with a merger, acquisition, divestiture, reorganization
or similar event, the Company shall promptly give to the Holders written notice thereof (and in no event shall such notice be
given less than 20 calendar days prior to the filing of such registration statement), and shall, subject to Section 3(c), include
as a Piggyback Registration all of the Registrable Securities specified in a written request delivered by the Holder thereof within
10 calendar days after receipt of such written notice from the Company. However, the Company may, without the consent of the Holders,
withdraw such registration statement prior to its becoming effective if the Company or such other stockholders have elected to
abandon the proposal to register the securities proposed to be registered thereby.

 

    	 	-6-	 

     

    

 

(c) Underwriting.
If a Piggyback Registration is for a registered public offering that is to be made by an underwriting, the Company shall so
advise the Holders of the Registrable Securities eligible for inclusion in such Registration Statement pursuant to Sections
3(b). In that event, the right of any Holder to Piggyback Registration shall be conditioned upon such
Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the
underwriting to the extent provided herein. All Holders proposing to sell any of their Registrable Securities through such
underwriting shall (together with the Company and any other stockholders of the Company selling their securities
through such underwriting) enter into an underwriting agreement in customary form with the underwriter selected for such
underwriting by the Company or the selling stockholders, as applicable. Notwithstanding any other provision of this Section,
if the underwriter or the Company determines that marketing factors require a limitation on the number of shares of Common
Stock or the amount of other securities to be underwritten, the underwriter, at its sole discretion, may exclude some or all
Registrable Securities from such registration and underwriting. The Company shall so advise all Holders (except those Holders
who failed to timely elect to include their Registrable Securities through such underwriting or have indicated to the Company
their decision not to do so), and indicate to each such Holder the number of shares of Registrable Securities that may be
included in the registration and underwriting, if any. The number of shares of Registrable Securities to be included in such
registration and underwriting shall be allocated among such Holders as follows:

 

(i)
If the Piggyback Registration was initiated by the Company, the number of shares that may be included in the registration and
underwriting shall be allocated first to the Company and then, subject to obligations and commitments existing as of the date
hereof, to all selling stockholders, including the Holders, who have requested to sell in the registration on a pro rata basis
according to the number of shares requested to be included therein; or

 

(ii)
If the Piggyback Registration was initiated by the exercise of demand registration rights by a stockholder or stockholders of
the Company (other than the Holders), then the number of shares that may be included in the registration and underwriting shall
be allocated first to such selling stockholders who exercised such demand and then, subject to obligations and commitments existing
as of the date hereof, to all other selling stockholders, including the Holders, who have requested to sell in the registration
on a pro rata basis according to the number of shares requested to be included therein.

 

No
Registrable Securities excluded from the underwriting by reason of the underwriter’s marketing limitation shall be included
in such registration and no liquidated damages as set forth in Section 3(d) shall accrue with respect to such excluded securities.
If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw such Holder’s Registrable
Securities therefrom by delivering a written notice to the Company and the underwriter. The Registrable Securities so withdrawn
from such underwriting shall also be withdrawn from such registration; provided, however, that, if by the withdrawal
of such Registrable Securities, a greater number of Registrable Securities held by other Holders may be included in such registration
(up to the maximum of any limitation imposed by the underwriters), then the Company shall offer to all Holders who have included
Registrable Securities in the registration the right to include additional Registrable Securities pursuant to the terms and limitations
set forth herein in the same proportion used above in determining the underwriter limitation.

 

(d)
Occurrence of Registration Event. If a Registration Event occurs, then the Company will make payments to each Holder of
Registrable Securities (a “Qualified Purchaser”), as liquidated damages for the amount of damages to the Qualified
Purchaser by reason thereof, at a rate equal to 0.50% of the purchase price per Unit paid by such Holder in the PPO for the Registrable
Securities then held by each Qualified Purchaser for each full period of 30 days of the Registration Default Period (which shall
be pro-rated for any period less than 30 days); provided, however, if a Registration Event occurs (or is continuing),
liquidated damages shall be paid only with respect to that portion of the Qualified Purchaser’s Registrable Securities that
cannot then be immediately resold in reliance on Rule 144. Notwithstanding the foregoing, the maximum amount of liquidated damages
that may be paid to any Qualified Purchaser pursuant to this Section 3(d) shall be an amount equal to 6% of the purchase price
per Unit paid by such Holder in the PPO for the Registrable Securities held by such Qualified Purchaser at the time of the first
occurrence of a Registration Event. Each such payment shall be due and payable within five days after the end of each full 30-day
period of the Registration Default Period until the termination of the Registration Default Period and within five days after
such termination. Such payments shall constitute the Qualified Purchaser’s exclusive remedy for such events. If the Company
fails to pay any partial liquidated damages or refund pursuant to this Section in full within seven days after the date payable,
the Company will pay interest thereon at a rate of 2% per annum (or such lesser maximum amount that is permitted to be paid by
applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all
such interest thereon, are paid in full. The Registration Default Period shall terminate upon (i) the filing of the Registration
Statement in the case of clause (a) of the definition of Registration Event, (ii) the SEC Effective Date in the case of clause
(b) of the definition of Registration Event, (iii) the ability of the Qualified Purchaser to effect sales pursuant to the Registration
Statement in the case of clause (c) of the definition of Registration Event, and (iv) the listing or inclusion and/or trading
of the Common Stock on an Approved Market, as the case may be, in the case of clause (d) of the definition of Registration Event.
The amounts payable as liquidated damages pursuant to this Section 3(d) shall be payable in lawful money of the United States.

 

    	 	-7-	 

     

    

 

(e)
Notwithstanding the provisions of Section 3(d) above:

 

(1)(a)
if the Commission does not declare the Registration Statement effective on or before the Registration Default Date, or (b) if
the Commission allows the Registration Statement to be declared effective at any time before or after the Registration Default
Date, subject to the withdrawal of certain Registrable Securities from the Registration Statement, and the reason for (a) or (b)
is the Commission’s determination that (x) the offering of any of the Registrable Securities constitutes a primary offering
of securities by the Company, (y) Rule 415 may not be relied upon for the registration of the resale of any or all of the Registrable
Securities, and/or (z) a Holder of any Registrable Securities must be named as an underwriter, the Holders understand and agree
that in the case of (b) the Company may reduce, on a pro rata basis, the total number of Registrable Securities to be registered
on behalf of each such Holder, and, in the case of (a) or (b), that a Holder shall not be entitled to any liquidated damages with
respect to the Registrable Securities not registered for the reason set forth in (a), or so reduced on a pro rata basis
as set forth in (b). In any such pro rata reduction, the number of Registrable Securities to be registered on such Registration
Statement will be reduced by the Registrable Securities represented by Investor Shares (applied, in the case that some Investor
Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Investor Shares
held by such Holders). In addition, any such affected Holder shall be entitled to Piggyback Registration rights after the Registration
Statement is declared effective by the Commission until such time as: (AA) all Registrable Securities have been registered pursuant
to an effective Registration Statement, (BB) the Registrable Securities may be resold without restriction pursuant to Rule 144
of the Securities Act, or (CC) the Holder agrees to be named as an underwriter in any such registration statement. The Holders
acknowledge and agree the provisions of this paragraph may apply to more than one Registration Statement; and

 

    	 	-8-	 

     

    

 

(2)
For not more than thirty (30) consecutive days or for a total of not more than sixty (60) days in any twelve (12) month period,
the Company may suspend the use of any prospectus included in any Registration Statement contemplated by this Section in the event
that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material non-public
information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the
best interests of the Company or (B) amend or supplement the affected Registration Statement or the related prospectus so that
such Registration Statement or prospectus shall not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the case of the prospectus in light of the
circumstances under which they were made, not misleading, including in connection with the filing of a post-effective amendment
to such Registration Statement in connection with the Company’s filing of an Annual Report on Form 10-K for any fiscal year
(an “Allowed Delay”); provided, that the Company shall promptly (a) notify each Holder in writing of the commencement
of an Allowed Delay, but shall not (without the prior written consent of an Holder) disclose to such Holder any material non-public
information giving rise to an Allowed Delay, (b) advise the Holders in writing to cease all sales under the Registration Statement
until the end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.

 

In
the event of an Allowed Delay, the liquidated damages set forth in Section 3(d) shall not accrue during such Allowed Delay.

 

4.
Registration Procedures for Registrable Securities. The Company will keep each Holder reasonably advised as to the filing
and effectiveness of the Registration Statement. At its expense with respect to the Registration Statement, the Company will:

 

(a)
prepare and file with the Commission with respect to the Registrable Securities, a Registration Statement on Form S-1, or any
other form for which the Company then qualifies or which counsel for the Company shall deem appropriate and which form shall be
available for the sale of the Registrable Securities in accordance with the intended methods of distribution thereof, and use
its commercially reasonable efforts to cause such Registration Statement to become effective and shall remain effective for a
period of one year or for such shorter period ending on the earlier to occur of (i) the date as of which all of the Holders as
selling stockholders thereunder may sell all of the Registrable Securities registered for resale thereon without restriction pursuant
to Rule 144 (or any successor rule thereto) promulgated under the Securities Act or (ii) the date when all of the Registrable
Securities registered thereunder shall have been sold (the “Effectiveness Period”). Thereafter, the Company
shall be entitled to withdraw such Registration Statement and the Purchasers shall have no further right to offer or sell any
of the Registrable Securities registered for resale thereon pursuant to the respective Registration Statement (or any prospectus
relating thereto);

 

    	 	-9-	 

     

    

 

(b)
if the Registration Statement is subject to review by the Commission, respond in a commercially reasonable manner to all comments
and diligently pursue resolution of any comments to the satisfaction of the Commission;

 

(c)
prepare and file with the Commission such amendments and supplements to such Registration Statement as may be necessary to keep
such Registration Statement effective during the Effectiveness Period;

 

(d)
furnish, without charge, to each Holder of Registrable Securities covered by such Registration Statement (i) a reasonable number
of copies of such Registration Statement (including any exhibits thereto other than exhibits incorporated by reference), each
amendment and supplement thereto as such Holder may reasonably request, (ii) such number of copies of the prospectus included
in such Registration Statement (including each preliminary prospectus and any other prospectus filed under Rule 424 of the Securities
Act) as such Holders may reasonably request, in conformity with the requirements of the Securities Act, and (iii) such other documents
as such Holder may require to consummate the disposition of the Registrable Securities owned by such Holder, but only during the
Effectiveness Period;

 

(e)
use its commercially reasonable efforts to register or qualify such registration under such other applicable securities laws of
such jurisdictions as any Holder of Registrable Securities covered by such Registration Statement reasonably requests and as may
be necessary for the marketability of the Registrable Securities (such request to be made by the time the applicable Registration
Statement is deemed effective by the Commission) and do any and all other acts and things necessary to enable such Holder to consummate
the disposition in such jurisdictions of the Registrable Securities owned by such Holder; provided, that the Company shall
not be required to (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify
but for this paragraph, (ii) subject itself to taxation in any such jurisdiction, or (iii) consent to general service of process
in any such jurisdiction.

 

(f)
notify each Holder of Registrable Securities, the disposition of which requires delivery of a prospectus relating thereto under
the Securities Act, of the happening of any event (as promptly as practicable after becoming aware of such event), which comes
to the Company’s attention, that will after the occurrence of such event cause the prospectus included in such Registration
Statement, if not amended or supplemented, to contain an untrue statement of a material fact or an omission to state a material
fact required to be stated therein or necessary to make the statements therein not misleading and the Company shall promptly thereafter
prepare and furnish to such Holder a supplement or amendment to such prospectus (or prepare and file appropriate reports under
the Exchange Act) so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not
contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein not misleading, unless suspension of the use of such prospectus otherwise is authorized herein or
in the event of a Blackout Period, in which case no supplement or amendment need be furnished (or Exchange Act filing made) until
the termination of such suspension or Blackout Period;

 

(g)
comply, and continue to comply during the Effectiveness Period, in all material respects with the Securities Act and the Exchange
Act and with all applicable rules and regulations of the Commission with respect to the disposition of all securities covered
by such Registration Statement;

 

    	 	-10-	 

     

    

 

(h)
as promptly as practicable after becoming aware of such event, notify each Holder of Registrable Securities being offered or sold
pursuant to the Registration Statement of the issuance by the Commission of any stop order or other suspension of effectiveness
of the Registration Statement;

 

(i)
use its commercially reasonable efforts to cause all the Registrable Securities covered by the Registration Statement to be quoted
on such Approved Market on which securities of the same class or series issued by the Company are then listed or traded;

 

(j)
provide a transfer agent and registrar, which may be a single entity, for the shares of Common Stock at all times;

 

(k)
if requested by the Holders, cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free,
to the extent permitted by applicable law, of all restrictive legends, and to enable such Registrable Securities to be in such
denominations and registered in such names as any such Holders may request;

 

(l)
during the Effectiveness Period, refrain from bidding for or purchasing any Common Stock or any right to purchase Common Stock
or attempting to induce any person to purchase any such security or right if such bid, purchase or attempt would in any way limit
the right of the Holders to sell Registrable Securities by reason of the limitations set forth in Regulation M of the Exchange
Act; and

 

(m)
take all other reasonable actions necessary to expedite and facilitate the disposition by the Holders of the Registrable Securities
pursuant to the Registration Statement.

 

5.
Suspension of Offers and Sales. Each Holder agrees that, upon receipt of any notice from the Company of the happening of
any event of the kind described in Section 4(f) hereof or of the commencement of a Blackout Period, such Holder shall discontinue
the disposition of Registrable Securities included in the Registration Statement until such Holder’s receipt of the copies
of the supplemented or amended prospectus contemplated by Section 4(f) hereof or notice of the end of the Blackout Period, and,
if so directed by the Company, such Holder shall deliver to the Company (at the Company’s expense) all copies (including,
without limitation, any and all drafts), other than permanent file copies, then in such Holder’s possession, of the prospectus
covering such Registrable Securities current at the time of receipt of such notice.

 

6.
Registration Expenses. The Company shall pay all expenses in connection with any registration obligation provided herein,
including, without limitation, all registration, filing, stock exchange fees, printing expenses, all fees and expenses of complying
with applicable securities laws, and the fees and disbursements of counsel for the Company and of its independent accountants;
provided, that, in any registration, each party shall pay for its own underwriting discounts and commissions and transfer
taxes. Except as provided in this Section and Section 9, the Company shall not be responsible for the expenses of any attorney
or other advisor employed by a Holder.

 

    	 	-11-	 

     

    

 

7.
Assignment of Rights. No Holder may assign its rights under this Agreement to any party without the prior written consent
of the Company; provided, however, that any Holder may assign its rights under this Agreement without such consent to a
Permitted Assignee as long as (a) such transfer or assignment is effected in accordance with applicable securities laws; (b) such
transferee or assignee agrees in writing to become subject to the terms of this Agreement; and (c) such Holder notifies the Company
in writing of such transfer or assignment, stating the name and address of the transferee or assignee and identifying the Registrable
Securities with respect to which such rights are being transferred or assigned.

 

8.
Information by Holder. A Holder with Registrable Securities included in any registration shall furnish to the Company such
information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities
as shall be required in order to comply with any applicable law or regulation in connection with the registration of such Holder’s
Registrable Securities or any qualification or compliance with respect to such Holder’s Registrable Securities and referred
to in this Agreement. A form of Selling Stockholder Questionnaire is attached as Exhibit A hereto for such purposes.

 

9.
Indemnification.

 

(a)
In the event of the offer and sale of Registrable Securities under the Securities Act, the Company shall, and hereby does, indemnify
and hold harmless, to the fullest extent permitted by law, each Holder, its directors, officers, partners, each other person who
participates as an underwriter in the offering or sale of such securities, and each other person, if any, who controls or is under
common control with such Holder or any such underwriter within the meaning of Section 15 of the Securities Act, against any losses,
claims, damages or liabilities, joint or several, and expenses to which the Holder or any such director, officer, partner or underwriter
or controlling person may become subject under the Securities Act, the Exchange Act, or any other federal or state law, insofar
as such losses, claims, damages, liabilities or expenses (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon any untrue statement of any material fact contained in any registration statement prepared
and filed by the Company under which Registrable Securities were registered under the Securities Act, any preliminary prospectus,
final prospectus or summary prospectus contained therein, or any amendment or supplement thereto, or any omission to state therein
a material fact required to be stated or necessary to make the statements therein in light of the circumstances in which they
were made not misleading, or any violation or alleged violation of the Securities Act, the Exchange Act, any state securities
law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection
with this Agreement; and the Company shall reimburse the Holder, and each such director, officer, partner, underwriter and controlling
person for any legal or any other expenses reasonably incurred by them in connection with investigating, defending or settling
any such loss, claim, damage, liability, action or proceeding; provided, that such indemnity agreement found in this Section
9(a) shall in no event exceed the net proceeds from the PPO received by the Company; and provided further, that the Company
shall not be liable in any such case (i) to the extent that any such loss, claim, damage, liability (or action or proceeding in
respect thereof) or expense arises out of or is based upon an untrue statement in or omission from such registration statement,
any such preliminary prospectus, final prospectus, summary prospectus, amendment or supplement in reliance upon and in conformity
with written information furnished to the Company by the Holder specifically for use in the preparation thereof or (ii) if the
person asserting any such loss, claim, damage, liability (or action or proceeding in respect thereof) who purchased the Registrable
Securities that are the subject thereof did not receive a copy of the preliminary prospectus or the final prospectus (or the final
prospectus as amended or supplemented) at or prior to the written confirmation of the sale of such Registrable Securities to such
person because of the failure of such Holder or underwriter to so provide such preliminary or final prospectus and the untrue
statement or omission of a material fact made in such preliminary prospectus was corrected in the amended preliminary or final
prospectus (or the final prospectus as amended or supplemented). Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Holders, or any such director, officer, partner, underwriter or controlling person
and shall survive the transfer of such shares by the Holder.

 

    	 	-12-	 

     

    

 

(b)
As a condition to including Registrable Securities in any registration statement filed pursuant to this Agreement, each Holder
agrees to be bound by the terms of this Section 9 and to indemnify and hold harmless, to the fullest extent permitted by law,
the Company, its directors and officers, and each other person, if any, who controls the Company within the meaning of Section
15 of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which the Company or any such
director or officer or controlling person may become subject under the Securities Act, the Exchange Act, or any other federal
or state law, to the extent arising out of or based solely upon: (x) such Holder’s failure to comply with the prospectus
delivery requirements of the Securities Act or (y) any untrue or alleged untrue statement of a material fact contained in any
registration statement, any prospectus, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein
or necessary to make the statements therein not misleading (i) to the extent, but only to the extent, that such untrue statement
or omission is contained in any information so furnished in writing by such Holder to the Company specifically for inclusion in
the registration statement or such prospectus or (ii) to the extent that (1) such untrue statements or omissions are based solely
upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the
extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities
and was reviewed and expressly approved in writing by such Holder expressly for use in the Registration Statement, such prospectus
or such form of prospectus or in any amendment or supplement thereto or (2) in the case of an occurrence of an event of the type
specified in Section 4(f) hereof, the use by such Holder of an outdated or defective prospectus after the Company has notified
such Holder in writing that the prospectus is outdated or defective and prior to the receipt by such Holder of the advice contemplated
in Section 4(f). In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of
the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

    	 	-13-	 

     

    

 

(c)
Promptly after receipt by an indemnified party of notice of the commencement of any action or proceeding involving a claim referred
to in this Section (including any governmental action), such indemnified party shall, if a claim in respect thereof is to be made
against an indemnifying party, give written notice to the indemnifying party of the commencement of such action; provided,
that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its
obligations under this Section, except to the extent that the indemnifying party is actually prejudiced by such failure to give
notice. In case any such action is brought against an indemnified party, unless in the reasonable judgment of counsel to such
indemnified party a conflict of interest between such indemnified and indemnifying parties may exist or the indemnified party
may have defenses not available to the indemnifying party in respect of such claim, the indemnifying party shall be entitled to
participate in and to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party and, after notice
from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party
shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by the latter in connection
with the defense thereof, unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified
and indemnifying parties arises in respect of such claim after the assumption of the defenses thereof or the indemnifying party
fails to defend such claim in a diligent manner, other than reasonable costs of investigation. Neither an indemnified nor an indemnifying
party shall be liable for any settlement of any action or proceeding effected without its consent. No indemnifying party shall,
without the consent of the indemnified party, consent to entry of any judgment or enter into any settlement, which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability
in respect of such claim or litigation. Notwithstanding anything to the contrary set forth herein, and without limiting any of
the rights set forth above, in any event any party shall have the right to retain, at its own expense, counsel with respect to
the defense of a claim.

 

(d)
If an indemnifying party does or is not permitted to assume the defense of an action pursuant to Sections 9(c) or in the case
of the expense reimbursement obligation set forth in Sections 9(a) and (b), the indemnification required by Sections 9(a) and
9(b) shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills
received or expenses, losses, damages, or liabilities are incurred.

 

(e)
If the indemnification provided for in Section 9(a) or 9(b) is held by a court of competent jurisdiction to be unavailable
to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall (i) contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage or expense as is appropriate to reflect the
proportionate relative fault of the indemnifying party on the one hand and the indemnified party on the other (determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission relates to
information supplied by the indemnifying party or the indemnified party and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such untrue statement or omission), or (ii) if the allocation
provided by clause (i) above is not permitted by applicable law or provides a lesser sum to the indemnified party than the
amount hereinafter calculated, not only the proportionate relative fault of the indemnifying party and the indemnified party,
but also the relative benefits received by the indemnifying party on the one hand and the indemnified party on the
other, as well as any other relevant equitable considerations. No indemnified party guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any indemnifying party who
was not guilty of such fraudulent misrepresentation.

 

    	 	-14-	 

     

    

 

(f)
Other Indemnification. Indemnification similar to that specified in this Section (with appropriate modifications) shall
be given by the Company and each Holder of Registrable Securities with respect to any required registration or other qualification
of securities under any federal or state law or regulation or governmental authority other than the Securities Act.

 

10. Rule
144. With a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation of
the Commission that may at any time permit the Holders to sell the Registrable Securities to the public without
registration, the Company agrees: (i) to make and keep public information available as those terms are understood in Rule
144, (ii) to file with the Commission in a timely manner all reports and other documents required to be filed by an issuer of
securities registered under the Securities Act or the Exchange Act pursuant to Rule 144,
(iii) as long as any Holder owns any Registrable Securities, to furnish in writing upon such Holder’s request a
written statement by the Company that it has complied with the reporting requirements of Rule 144 and of the Securities Act
and the Exchange Act, and to furnish to such Holder a copy of the most recent annual or quarterly report of the Company, and
such other reports and documents so filed by the Company as may be reasonably requested in availing such Holder of any rule
or regulation of the Commission permitting the selling of any such Registrable Securities without registration and (iv)
undertake any additional actions commercially reasonably necessary to maintain the availability of the use of Rule
144.

 

11.
Independent Nature of Each Purchaser’s Obligations and Rights. The obligations of each Purchaser under this Agreement
are several and not joint with the obligations of any other Purchaser, and each Purchaser shall not be responsible in any way
for the performance of the obligations of any other Purchaser under this Agreement. Nothing contained herein and no action taken
by any Purchaser pursuant hereto, shall be deemed to constitute such Purchasers as a partnership, an association, a joint venture,
or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect
to such obligations or the transactions contemplated by this Agreement. Each Purchaser shall be entitled to independently protect
and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for
any other Purchaser to be joined as an additional party in any proceeding for such purpose.

 

12.
Miscellaneous.

 

(a) Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the United States of America and
the State of New York, both substantive and remedial, without regard to New York conflicts of law principles. Any
judicial proceeding brought against either of the parties to this Agreement or any dispute arising out of this Agreement or
any matter related hereto shall be brought in the courts of the State of New York, New York County, or in the United States
District Court for the Southern District of New York and, by its execution and delivery of this Agreement, each party to
this Agreement accepts the jurisdiction of such courts. The foregoing consent to jurisdiction shall not be deemed to confer
rights on any person other than the parties to this Agreement.

 

    	 	-15-	 

     

    

 

(b)
Remedies. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under
this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. The
Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason
of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific
performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

(c)
Successors and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be
binding upon, the successors, Permitted Assignees, executors and administrators of the parties hereto.

 

(d)
No Inconsistent Agreements. The Company has not entered, as of the date hereof, and shall not enter, on or after the date
of this Agreement, into any agreement with respect to its securities that would have the effect of impairing the rights granted
to the Holders in this Agreement or otherwise conflicts with the provisions hereof.

 

(e)
Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with regard
to the subjects hereof.

 

(f)
Notices, etc. All notices or other communications which are required or permitted under this Agreement shall be in writing
and sufficient if delivered by hand, by facsimile transmission, by registered or certified mail, postage pre-paid, by electronic
mail, or by courier or overnight carrier, to the persons at the addresses set forth below (or at such other address as may be
provided hereunder), and shall be deemed to have been delivered as of the date so delivered:

 

If
to the Company to: 

 

Motus
GI Holdings, Inc.

150
Union Square Drive

New
Hope, PA 18938

 

with
copy to:

 

Lowenstein
Sandler LLP

1251
Avenue of the Americas

New
York, NY 10020

Attn:
Steven M. Skolnick, Esq.

Facsimile: (973) 597-2477

 

    	 	-16-	 

     

    

 

If
to the Purchasers:

 

To
each Purchaser at the address set forth on the signature page hereto or at such other address as any party shall have furnished
to the other parties in writing.

 

(g)
Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any Holder, upon any breach
or default of the Company under this Agreement, shall impair any such right, power or remedy of such Holder nor shall it be construed
to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereunder occurring;
nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter
occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Holder of any breach or default
under this Agreement, or any waiver on the part of any Holder of any provisions or conditions of this Agreement, must be in writing
and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, or
by law or otherwise afforded to any holder, shall be cumulative and not alternative.

 

(h)
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be enforceable against
the parties actually executing such counterparts, and all of which together shall constitute one instrument. In the event that
any signature is delivered by facsimile transmission or electronic transmission via .PDF file, such signature shall create a valid
and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as
if such facsimile or electronic signature page were an original thereof.

 

(i)
Severability. In the case any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality
and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

(j)
Amendments. The provisions of this Agreement may be amended at any time and from time to time, and particular provisions
of this Agreement may be waived, with and only with an agreement or consent in writing signed by the Company and the Majority
Holders. The Purchasers acknowledge that by the operation of this Section, the Majority Holders may have the right and power to
diminish or eliminate all rights of the Purchasers under this Agreement.

 

[SIGNATURE
PAGES FOLLOW]

 

    	 	-17-	 

     

    

 

This
Registration Rights Agreement is hereby executed as of the date first above written.

 

 

	 	COMPANY:
	 	 
	 	MOTUS HOLDINGS INC.
	 	 	 
	 	By:
    	        
	 	Name:	 
	 	Title:	 

 

EACH
PURCHASER’S SIGNATURE TO THE SUBSCRIPTION AGREEMENT DATED OF VEN DATE HEREWITH SHALL CONSTITUTE THE PURCHASER’S SIGNATURE
TO THIS 

REGISTRATION RIGHTS AGREEMENT.

 

[Signature
Page to Registration Rights Agreement]

 

    	 		 

     

    

 

Exhibit
A

 

Selling
Stockholder Questionnaire

 

[See
Attached.]

 

    	 		 

     

    

 

MOTUS
GI HOLDINGS, INC.

STOCKHOLDERS’ QUESTIONNAIRE

 

The
following information is requested from you in connection with the preparation and filing by Motus GI Holdings, Inc. (the “Company”)
of a Registration Statement on Form S-1 or other appropriate form (the “Registration Statement”) with the Securities
and Exchange Commission (the “SEC”) covering the sale of shares of the Company’s common stock, including shares
of common stock underlying certain Warrants (the “Registrable Securities”) by certain stockholders of the Company.

 

We
would appreciate your answering all of the questions included in this questionnaire, even though your answers may be in the negative,
so that the Company will have a record of your responses for use in connection with the preparation of the Registration Statement.
It is requested that you give careful attention to each question and that you complete this questionnaire personally.

 

In
order to assist you in completing this questionnaire, certain terms used herein are defined in the appendix which is attached
to this questionnaire. Each of such defined terms has been bolded and italicized for identification. The term “person,”
as used in this questionnaire, means any natural person, company, government or political subdivision, agency or instrumentality
of a government.

 

After
you have completed the following questionnaire, please send the completed questionnaire by e-mail to RBee@lowenstein.com,
or fax to the attention of Robert Bee, Esq. at (973)-597-2400, or overnight courier as soon as possible to the attention of Robert
Bee, Esq. at Lowenstein Sandler LLP, 65 Livingston Avenue, Roseland, NJ 07068.

 

*********************

 

    	 	A-1	 

     

    

 

GENERAL
INFORMATION

 

1.
Please provide your full name and address or the full name and address of the entity on whose behalf you are completing this questionnaire.
The address may be a business, mailing or residence address.

 

	Name:	
	 	 
	Address:	

 

If
you are answering this questionnaire on behalf of a corporate entity, please state your name and position with the selling shareholder.

 

	Name:	 
	 	 
	Position:	 

 

	2.
    Name the Control Person of your organization:	 

 

3.
(a) Are you a broker-dealer registered pursuant to Section 15 of the Exchange Act?

 

[  ]
Yes

[  ]
No

 

(b)
If your response to Item 3(a) above is no, are you an “affiliate” of a broker-dealer registered pursuant to Section
15 of the Exchange Act?

 

[  ]
Yes

[  ]
No

 

For
the purposes of this Item 3(b), an “affiliate” of a registered broker-dealer shall include any company that
directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with,
such broker-dealer, and does not include any individuals employed by such broker-dealer or its affiliates.

 

(c)
Please provide the full legal name of the person through which you hold the Registrable Securities—(i.e. name of your broker,
if applicable, through which your Registrable Securities are held):

 

	Name
    of broker:	 	 
	 	 	 
	Contact
    person:	 	 
	 	 	 
	Telephone
    No.:	 	 

 

    	 	A-2	 

     

    

 

SECURITIES
HOLDINGS

 

Please
fill in all blanks in the following questions related to your beneficial ownership of the Company’s common
stock. Generally, a beneficial owner of a security is a person who, directly or indirectly, through any contract,
arrangement, understanding, relationship or otherwise has or shares either: (i) voting power, which includes the power to vote,
or to direct the voting of such security; and/or (ii) investment power, which includes the power to dispose, or to direct the
disposition of, such security, even though he or she may not be the holder of record of the securities. Thus, securities held
in “street name” over which you exercise voting or investment power would be considered beneficially owned
by you. Other examples of indirect ownership include ownership by a partnership in which you are a partner or by an estate or
trust of which you or any member of your immediate family is a beneficiary. Ownership of securities held in the
names of your spouse, minor children or other relatives who live in the same household may be attributed to you.

 

If
you have any reason to believe that any interest in securities of the Company which you may have, however remote, is a beneficial
interest, please describe such interest. For purposes of responding to this questionnaire, it is preferable to err on the side
of inclusion rather than exclusion. Where the SEC’s interpretation of beneficial ownership would require disclosure
of your interest or possible interest in certain securities of the Company, and you believe that you do not actually possess the
attributes of beneficial ownership, an appropriate response is to disclose the interest and at the same time disclaim
beneficial ownership of the securities.

 

In
the table below, please indicate the shares of common stock, including shares of common stock underlying any option, warrant or
other convertible security, of the Company or any of its subsidiaries which you beneficially owned as of the date
hereof.

 

For
each holding use the fields in the table to:

 

	 	●	State
    the nature of the holding (i.e., held in your own name, jointly, as a trustee or beneficiary of a trust, as a custodian,
    as an executor, in discretionary accounts, by your spouse or minor children, by a partnership of which you are a partner,
    etc.), and
	 	 	 
	 	●	State
    whether you are the beneficial owner by reason of (i) sole voting power, (ii) shared voting power, (iii) sole
    investment power, (iv) shared investment power, (v) the right to acquire stock within 60 days of the end of the calendar year,
    (vi) the right to acquire stock with the purpose of changing or influencing control; and/or (vii) a security-based swap that
    you hold that gives you voting or investment power over the underlying Company stock (even though you may not directly hold
    the underlying Company stock).
	 	 	 
	 	●	Indicate
    in the Remarks column below whether you have sole or shared voting or investment power with respect to any such securities,
    and in what capacity (i.e., individual, general partner, trustee) you have such power or powers.
	 	 	 
	 	●	If
    you wish to disclaim beneficial ownership of any shares listed, so indicate by writing the word “Disclaim”
    in the Remarks column below; you understand that such shares will be shown separately from your beneficial holdings and an
    appropriate disclaimer set forth.
	 	 	 
	 	●	If
    any of the shares listed are subject to any claim, encumbrance, pledge or lien, so indicate in the Remarks column.

 

    	 	A-3	 

     

    

 

	Number
    of shares1	 	Registered
    in name of 	 	Beneficially
    Owned by	 	Number
    of Registrable Securities	 	Remarks
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 

 

 

1
Including the number of shares underlying warrants, options or convertible securities. Please list such shares as a separate
line item.

 

    	 	A-4	 

     

    

 

1.
Your Interest in the Registrable Securities.

 

	(a)	 	State
    the number of such Registrable Securities beneficially owned by you.

 

	 	Common
    stock:	 	 
	 	 	 	 
	 	Warrants:	 	 

 

	(b)	 	Other
    than as set forth in your response to Item 1(a) above, do you beneficially own any other securities of the Company?

 

[  ]
Yes

 

[  ]
No

 

	(c)	 	If
    your answer to Item 1(b) above is yes, state the type, the aggregate amount and CUSIP No. (if applicable) of such other securities
    of the Company beneficially owned by you:

 

	 	Type:
    	 
	 	 	 
	 	Aggregate
    amount: 	 
	 	 	 
	 	CUSIP
    No.:	 

 

	(d)	 	Did
    you acquire the securities listed in Item 1(a) above in the ordinary course of business?

 

[  ]
Yes

 

[  ]
No

 

	(e)	 	At
    the time of your purchase of the securities listed in Item 1(a) above, did you have any agreements or understandings, directly
    or indirectly, with any person to distribute the securities?

 

[  ]
Yes

 

[  ]
No

 

	(f)	 	If
    your response to Item 1(e) above is yes, please describe such agreements or understandings:

 

	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 

 

    	 	A-5	 

     

    

 

2.
Nature of Your Beneficial Ownership.

 

(a)
Does someone other than you have control over the securities listed in Item 1(a) above?

 

[  ]
Yes

 

[  ]
No

 

(b)
If your response to Item 2(a) above is yes, name your controlling shareholder(s) or other person who has the ability to
exercise control over you (the “Controlling Entity”). If the Controlling Entity is not a natural person and is
not a publicly held entity, name each shareholder of such Controlling Entity. If any of these named shareholders are not
natural persons or publicly held entities, please provide the same information. This process should be repeated until you
reach natural persons or a publicly held entity.

 

		(A)(i)	Full
                                         legal name of Controlling Entity(ies) or natural person(s) with who have sole or shared
                                         voting or dispositive power over the Registrable Securities:
	 	 	 
	 	 	Business
address (including street address) (or residence if no business address), telephone number and facsimile number of such person(s):

 

	 	Address:
    		 
	 		 
	 	Telephone:		 
	 	 	 	 
	 	Fax:		 
	 	 		 
	 	Name
    of shareholder:;		 
	 		 
	 		 
	 		 
	 		 

 

    	 	A-6	 

     

    

 

	 	(B)(i)	Full
    legal name
    of Controlling Entity(ies):	 
	 	 		 
		 	 	 
	 	 	 	 
	 	 	Business address (including street address) (or residence if no business address), telephone number and facsimile number of such person(s):
	 	 	 
	 	 	Address:
	 	 
	 	 	 	 
	 	 	Telephone:	 	 
	 	 	 	 
	 	 	Fax:
	 	 
	 	 	 	 
	 	 	Name
of shareholders	 	 
	 	 	 	 

 

If
you need more space for this response, please attach additional sheets of paper. Please be sure to indicate your name and the
number of the item being responded to on each such additional sheet of paper, and to sign each such additional sheet of paper
before attaching it to this Questionnaire. Please note that you may be asked to answer additional questions depending on your
responses to the following questions.

 

    	 	A-7	 

     

    

 

3.
5% Stockholders

 

To
the best of my knowledge, all persons (including myself and my associates and including corporations, partnerships,
trusts, associations and other such groups) who beneficially own more than 5% of any class of the Company’s
stock are described below:

 

	Name
    of

 Benefiacial 

Owner	 	Class
    of Shares

 Beneficiaaly 

Owned	 	Holder
    of Voting

 or Investment

 Power

 

    	 	A-8	 

     

    

 

4.
No Adverse Interest

 

All
interests I or my associates have or will have that are adverse to the Company interests in any pending or contemplated
legal proceeding or government investigation to which the Company is or will be a party (or to which its property may be subject)
are described below:

 

    	 	A-9	 

     

    

 

5.
Voting Arrangement

 

All
voting trusts or similar agreements or arrangements of which I have knowledge pursuant to which more than 5% of
the Company’s outstanding common stock, on an as converted basis, is subject are described below:

 

	Names
    and Addresses of Voting Trustees	 	Voting
        Rights and Other Powers

        Under
        Trust, Agreement or Arrangement

 

    	 	A-10	 

     

    

 

6.
Change in Control

 

All
arrangements of which I have knowledge, including any pledge by any person of securities of the Company, the operations
of which may at a subsequent date result in a change in control of the Company, are described below:

 

    	 	A-11	 

     

    

 

TRANSACTIONS
WITH THE COMPANY

 

1.
Information regarding all material interests of yours or your associates in any actual or proposed transaction during
the last three fiscal years to which the Company was or is to be a party (and that are identified under “Securities Holdings”
above) is provided below. No such transaction need be described if:

 

(a)
the amount involved (including all periodic installments in the case of any lease or other agreement provided for periodic payments
or installments and including the value of all transactions In a series of similar transactions) does not exceed $60,000;

 

(b)
the rates or charges involved in the transaction are fixed by law or governmental authority or determined by competitive bids;

 

(c)
the services involved are as a bank depositary of funds, transfer agent, registrar, trustee under a trust indenture or other similar
service;

 

(d)
your interest arises solely from my ownership of securities of the Company and you received no extra or special benefit not shared
on a pro rata basis by all other holders of securities in the same class;

 

(e)
your interest in the corporation that is a party to the transaction is solely as a director; or

 

(f)
your interest arose solely as an officer and/or director of the Company (e.g., your compensation arrangement with the Company).

 

Description:

 

    	 	A-12	 

     

    

 

AFFILIATION
WITH ACCOUNTANTS OR ATTORNEYS

 

Described
below is any interest, affiliation or connection you have with any law firm or accounting firm that has been retained by the Company
during the last three fiscal years or is proposed to be retained by the Company:

 

    	 	A-13	 

     

    

 

CONTRACTS
WITH THE COMPANY

 

Described
below are all contracts with the Company or in which the Company has a beneficial interest, or to which the Company has succeeded
by assumption or assignment, to which you or any of your associates is a party, which are to be performed in whole
or in part at or after the date of the proposed filing of the Registration Statement, or which were made not more than two years
prior thereto:

 

    	 	A-14	 

     

    

 

FINRA-RELATED
QUESTIONS

 

1.
Are you (i) a “member” of the Financial Industries Regulatory Authority, Inc. (“FINRA”), (ii) an
“affiliate” of a member of FINRA, (iii) a “person associated with a member” or “associated person
of a member” of FINRA or (iv) associated with an “underwriter or related person” with respect to the proposed
public offering of the Company’s securities?

 

	 	Yes
           	 	No
       	 

 

For
the sole purpose of this Question: (i) FINRA generally defines a “member” to include any broker or dealer admitted
to membership in FINRA or any officer or partner of such a member or the executive representative of such member or the substitute
for such representative; (ii) the term “affiliate” means a person that directly, or indirectly through one or more
intermediaries, controls, or is controlled by, or is in common control with the person specified. Persons who have acted or are
acting on behalf or for the benefit of a person include, but are not necessarily limited to, directors, officers, employees, agents,
consultants and sales representatives; (iii) FINRA generally defines a “person associated with a member” or “associated
person of a member” to include every sole proprietor, partner, officer, director or branch manager of any member, or any
natural person occupying a similar status or performing similar functions, or any natural person engaged in the investment banking
or securities business who is directly or indirectly controlling or controlled by such member (for example, any employee), whether
or not any such person is registered or exempt from registration with FINRA; and (iv) the term “underwriter or related person”
includes, with respect to a proposed offering, underwriters, underwriters’ counsel, financial consultants and advisers,
finders, members of the selling or distribution group, and any and all other persons associated with or related to any such persons.

 

If
yes, kindly describe such relationship (whether direct or indirect) and please respond to Questions (2) and (3) below; if no,
please proceed to Question (4).

 

2.
Please set forth information as to all purchases and acquisitions (including contracts for purchase or acquisition) of securities
of the Company by you, regardless of the time acquired or the source from which derived:

 

	Seller
    or	 	Amount
    and	 	Price
    or Other	 	 
	Prospective
    Seller	 	Nature
    of Securities	 	Consideration	 	Date

 

    	 	A-15	 

     

    

 

3.
In connection with your direct or indirect affiliation or association with a “member” of FINRA as set forth above
in Question (1), please furnish the identity of such FINRA member and any information, if known, as to whether such FINRA member
intends to participate in any capacity in this proposed initial public offering, including the details of such participation:

 

4.
Please describe any underwriting compensation and arrangement or any dealings known to you between any “underwriter or related
person”, “member” of FINRA, “affiliate” of a member of FINRA, “person associated with a member”,
or “associated person of a member” of FINRA on the one hand and the Company or controlling shareholder thereof on
the other hand, other than information relating to the proposed initial public offering of the Company:

 

5.
Please set out below any information, if known, as to whether any “member” of FINRA, any “underwriter or related
person”, “affiliate” or a member of FINRA, “person associated with a member” or “associated
person of a member” of FINRA may receive any portion of the net offering:

 

    	 	A-16	 

     

    

 

For
subscribers answering “Yes” to Item 1 above:

 

The
undersigned FINRA member form acknowledges receipt of the notice required by Article 3, Sections 28(a) and (b) of the Rules of
Fair Practice.

 

	 	 
	Name
    of FINRA Member Firm	 

 

	By:	 	 	Date:	 
	 	Authorized
    officer	 	 	 

 

    	 	A-17	 

     

    

 

The
undersigned (including its donees or pledgees) intends to distribute the Registrable Securities listed above pursuant to the Registration
Statement only as follows (if at all): Such Registrable Securities may be sold from time to time directly by the undersigned or,
alternatively, through underwriters, broker-dealers or agents. If the Registrable Securities are sold through underwriters, broker-dealers
or agents, the selling holder will be responsible for underwriting discounts or commissions or agents’ commissions. Such
Registrable Securities may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of sale,
at varying prices determined at the time of sale or at negotiated prices. Such sales may be effected in transactions (which may
involve block transactions) (i) on any national securities exchange or quotation service on which the Registrable Securities may
be listed or quoted at the time of sale, (ii) in the over-the-counter market, or (iii) in transactions otherwise than on such
exchanges or services or in the over-the-counter market.

 

I
understand that material misstatements or the omission of material facts in the Registration Statement may give rise to civil
and criminal liabilities to the Company, to each officer and director of the Company signing the Registration Statement and other
persons signing the Registration Statement. I will notify you and the Company of any misstatement of a material fact in the Registration
Statement or any amendment thereto, and of the omission of any material fact necessary to make the statements contained therein
not misleading, as soon as practicable after a copy of the Registration Statement or any such amendment has been provided to me.
The undersigned acknowledges and agrees that the Company and its legal counsel shall be entitled to rely on the responses in this
Questionnaire in all matters pertaining to the Registration Statement and the sale of any Registrable Securities pursuant to the
Registration Statement.

 

I
confirm that the foregoing statements are correct, to the best of my knowledge and belief.

 

	Dated:
    	 	 

 

	 	Very
    truly yours,
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	(Typed
    or Printed Name)

 

    	 	A-18	 

     

    

 

DEFINITIONS

 

The
term “arrangement” means any plan, contract, authorization or understanding whether or not set forth
in a formal document.

 

The
term “associate” as used throughout this questionnaire, means (a) any corporation or organization (other
than the Company) of which I am an officer, director or partner or of which I am, directly or indirectly, the beneficial owner
of 5% or more of any class of equity securities, (b) any trust or other estate in which I have a substantial beneficial interest
or as to which I serve as trustee or in a similar capacity, (c) my spouse, (d) any relative of my spouse or any relative of mine
who has the same home as me or who is a director or officer or key executive of the Company, (e) any partner, syndicate member
or person with whom I have agreed to act in concert with respect to the acquisition, holding, voting or disposition of shares
of the Company’s securities.

 

The
term “beneficial owner” when used in connection with the ownership of a security includes any person
who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise has or shares:

 

(a)
voting power which includes the power to vote, or to direct the voting of, such security;

and/or

 

(b)
investment power which includes the power to dispose, or to direct the disposition, of such security.

 

The
term “beneficial ownership” or “beneficially owned” when used in connection
with the ownership of securities, means (a) any interest in a security which entitles me to any of the rights or benefits of ownership
even though I may not be the owner of record or (b) securities owned by me directly or indirectly, including those held by me
for my own benefit (regardless of how registered) and securities held by others for my benefit (regardless of how registered),
such as by custodians, brokers, nominees, pledgees, etc., and including securities held by an estate or trust in which I have
an interest as legatee or beneficiary, securities owned by a partnership of which I am a partner, securities held by a personal
holding company of which I am a stockholder, etc., and securities held in the name of my spouse, minor children and any relative
(sharing the same home).

 

The
term “control” (including the terms “controlling,” “controlled by” and “under
common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the
management and policies of a person, whether through the ownership of voting securities, by contract or otherwise.

 

The
term “immediate family” means any relationship by blood, marriage or adoption, not more remote than
first cousin.

 

The
term “material,” when used in this questionnaire to qualify a requirement for the furnishing of information
as to any subject, limits the information required to those matters as to which an average prudent investor ought reasonably to
be informed before purchasing the Common Stock of the Company.

 

    	 	A-19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]